5'-Azacitidine for therapy-related myelodysplastic syndromes after non-Hodgkin lymphoma treatment |
| |
| Authors: | Breccia Massimo Salaroli Adriano Loglisci Giuseppina Martelli Maurizio D'Elia Gianna Maria Nanni Mauro Mauro Francesca Romana Alimena Giuliana |
| |
| Affiliation: | Department of Cellular Biotechnologies and Hematology, Sapienza University, Via Benevento 6, 00161 Rome, Italy |
| |
| Abstract: | Therapy-related myelodysplastic syndromes are possible complications in patients treated for previous hematologic malignancies. Therapeutic strategies in these type of disorders are still not well defined: azacitidine has been recently approved for the treatment of higher risk myelodysplastic syndromes, but few data are published relating possible efficacy in therapy-related dysplastic disorders. We reported here 4 patients treated with azacitidine for therapy related dysplasia after chemotherapy for non-Hodgkin lymphoma. |
| |
| Keywords: | Azacitine Therapy-related MDS Efficacy |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ |
